Analyst Price Targets — REGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 9, 2026 11:13 am | Biren Amin | Piper Sandler | $854.00 | $662.88 | TheFly | Regeneron price target lowered to $854 from $855 at Piper Sandler |
| July 8, 2026 11:39 am | Terence Flynn | Morgan Stanley | $730.00 | $676.23 | TheFly | Regeneron price target lowered to $730 from $788 at Morgan Stanley |
| July 7, 2026 1:13 pm | — | Truist Financial | $769.00 | $670.54 | TheFly | Regeneron price target lowered to $769 from $778 at Truist |
| July 6, 2026 2:25 pm | — | HSBC | $800.00 | $643.00 | TheFly | Regeneron price target lowered to $800 from $990 at HSBC |
| July 6, 2026 10:46 am | — | Cantor Fitzgerald | $750.00 | $654.27 | StreetInsider | Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea OpticsMember Login |
| May 19, 2026 10:43 am | John Newman | Canaccord Genuity | $875.00 | $629.68 | TheFly | Regeneron price target lowered to $875 from $1,057 at Canaccord |
| May 18, 2026 6:48 pm | Alexandria Hammond | Wolfe Research | $860.00 | $629.36 | TheFly | Regeneron price target lowered to $860 from $900 at Wolfe Research |
| May 18, 2026 12:40 pm | — | Evercore ISI | $825.00 | $619.84 | TheFly | Regeneron price target lowered to $825 from $875 at Evercore ISI |
| May 18, 2026 12:30 pm | — | RBC Capital | $707.00 | $619.62 | TheFly | Regeneron price target lowered to $707 from $762 at RBC Capital |
| May 18, 2026 12:18 pm | — | Truist Financial | $778.00 | $619.95 | TheFly | Regeneron price target lowered to $778 from $796 at Truist |
Latest News for REGN
LOS ANGELES--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REGN.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Regeneron between August 1, 2025 and May 15, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may…
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals,
LOS ANGELES--(BUSINESS WIRE)---- $REGN--REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Regeneron (REGN) To Contact Him Directly To Discuss Their Options
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.